Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-023586

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Marilyn J. Purchase
Officer — Corp. Exec. VP of Operations
Period of report
Jul 7, 2014
Accepted (ET)
Mar 30, 2015 · 6:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jul 7, 2014F1,239$8.75D31,375D
Common StockF1Oct 3, 2014F519$11.41D30,856D
Common StockF3Mar 26, 2015A14,046$0.00A44,902D
Common StockF4,F5holding———16,044ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F6$14.95Mar 26, 2015A42,054A—Mar 26, 2025Common Stock42,05442,054D

Explanation of responses